Beckman Coulter, Inc.: Device Recall
Recall #Z-0265-2025 · 09/05/2024
Class II: Risk
Recall Details
- Recall Number
- Z-0265-2025
- Classification
- Class II
- Product Type
- Device
- Recalling Firm
- Beckman Coulter, Inc.
- Status
- Ongoing
- Date Initiated
- 09/05/2024
- Location
- Chaska, MN, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 465,481 kits
Reason for Recall
IFUs for the device incorrectly states the biotin interference was remediated. The issue could result in potentially false-low results.
Product Description
Access Thyroglobulin Antibody II, REF A32898, containing Instructions for Use, IFU REF B14994, B63978, and A38168. The Access Thyroglobulin Antibody II (TgAb) assay is used for the quantitative determination of thyroglobulin antibody levels in human serum and plasma using the Access Immunoassay Systems.
Distribution Pattern
Distribution was made nationwide to the U.S., including Puerto Rico. There was government distribution but no military distribution. Foreign distribution was made to Mexico.
Other Recalls by Beckman Coulter, Inc.
- Class II: Risk 12/23/2025
- Class II: Risk 11/26/2025
- Class II: Risk 11/26/2025
- Class II: Risk 11/10/2025
- Class II: Risk 11/07/2025
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.